126 related articles for article (PubMed ID: 9215699)
1. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
Brown DR; Herms JW; Schmidt B; Kretzschmar HA
Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35.
Hope J; Shearman MS; Baxter HC; Chong A; Kelly SM; Price NC
Neurodegeneration; 1996 Mar; 5(1):1-11. PubMed ID: 8731376
[TBL] [Abstract][Full Text] [Related]
3. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.
Brown DR; Schmidt B; Kretzschmar HA
Nature; 1996 Mar; 380(6572):345-7. PubMed ID: 8598929
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.
Forloni G; Bugiani O; Tagliavini F; Salmona M
Mol Chem Neuropathol; 1996; 28(1-3):163-71. PubMed ID: 8871955
[TBL] [Abstract][Full Text] [Related]
5. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides.
Agostinho P; Oliveira CR
Eur J Neurosci; 2003 Mar; 17(6):1189-96. PubMed ID: 12670307
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
[TBL] [Abstract][Full Text] [Related]
7. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
Brown DR
Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
[TBL] [Abstract][Full Text] [Related]
8. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
[TBL] [Abstract][Full Text] [Related]
9. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.
White AR; Maher F; Brazier MW; Jobling MF; Thyer J; Stewart LR; Thompson A; Gibson R; Masters CL; Multhaup G; Beyreuther K; Barrow CJ; Collins SJ; Cappai R
Brain Res; 2003 Mar; 966(2):231-44. PubMed ID: 12618346
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
[TBL] [Abstract][Full Text] [Related]
11. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment.
Brown DR; Herms J; Kretzschmar HA
Neuroreport; 1994 Oct; 5(16):2057-60. PubMed ID: 7865744
[TBL] [Abstract][Full Text] [Related]
12. Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels.
Silei V; Fabrizi C; Venturini G; Salmona M; Bugiani O; Tagliavini F; Lauro GM
Brain Res; 1999 Feb; 818(1):168-70. PubMed ID: 9914452
[TBL] [Abstract][Full Text] [Related]
13. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
14. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
[TBL] [Abstract][Full Text] [Related]
15. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
16. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
17. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions.
Tu J; Chen B; Yang L; Qi K; Lu J; Zhao D
J Mol Neurosci; 2015 Jun; 56(2):509-18. PubMed ID: 25869610
[TBL] [Abstract][Full Text] [Related]
19. Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.
Thellung S; Gatta E; Pellistri F; Villa V; Corsaro A; Nizzari M; Robello M; Florio T
Neurotox Res; 2017 Oct; 32(3):381-397. PubMed ID: 28540665
[TBL] [Abstract][Full Text] [Related]
20. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
